What’s the current market cap for Thermo Fisher Scientific stock?

Thermo Fisher Scientific (TMO) has a market cap of $174bn as of June 25, 2026.

What is the P/E ratio for Thermo Fisher Scientific stock?

The price to earnings (P/E) ratio for Thermo Fisher Scientific (TMO) stock is 25.8 as of June 25, 2026.

Does Thermo Fisher Scientific stock pay dividends?

Yes, the Thermo Fisher Scientific (TMO) stock pays dividends to shareholders. As of June 25, 2026, the dividend rate is $1.76 and the yield is 0.4%. Thermo Fisher Scientific has a payout ratio of 9.48% on a trailing twelve-month basis.

When is the next Thermo Fisher Scientific dividend payment date?

The next Thermo Fisher Scientific (TMO) dividend payment is scheduled for July 15, 2026.

What is the beta indicator for Thermo Fisher Scientific?

Thermo Fisher Scientific (TMO) has a beta rating of 0.88. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy Thermo Fisher Scientific stock | $TMO Share Price

About Thermo Fisher Scientific

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).

Ticker

$TMO

Sector

Health

Primary listing

NYSE

Employees

125,000

Headquarters

Waltham, United States

Website

www.thermofisher.com

TMO Metrics

BasicAdvanced

$174bn

25.80

$18.19

0.88

$1.76

0.40%

What the Analysts think about TMO

Analyst ratings (Buy, Hold, Sell) for Thermo Fisher Scientific stock.

Bulls say / Bears say

Q1 revenue grew 6% to $11.01B, beating market forecasts and starting the year strongly.

Revenue from Laboratory Products & Biopharma Services rose about 7% to $6.04B, making up for other areas' weakness and boosting overall results.

Adjusted EPS came in at $5.44, above the $5.24 consensus, showing solid margin management despite broader economic pressures.

Organic revenue growth was just 1% in Q1, showing that headline growth depends mainly on acquisitions and currency effects.

The Analytical Instruments segment had flat revenue of $1.72B, with a 2% organic decline, pointing to persistent demand weakness in academic and applied markets.

Management cautioned that demand from U.S. and Chinese academic and government clients will stay weak, and noted inflationary risks linked to the Iran war, indicating possible challenges ahead.

Data summarised monthly by Lightyear AI. Last updated on 1 Jun 2026.

TMO Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

TMO Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

TMO News

AllArticlesVideos

Thermo Fisher Scientific Showcases New Capabilities Across Manufacturing, Clinical Development and AI-Enabled Research at BIO International 2026

Business Wire·3 days ago

West Pharma names former Thermo Fisher executive Lagarde as CEO

Reuters·3 weeks ago

Thermo Fisher Scientific Announces Quarterly Dividend

Business Wire·1 month ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.